Issue Navigation
-
Review
-
172-177
Santa T
Drug Discov Ther. 2013; 7(5):172-177.
DOI: 10.5582/ddt.2013.v7.5.172
-
178-184
Monoclonal antibody-related drugs for cancer therapy.
Li GN, Wang SP, Xue X, Qu XJ, Liu HP
Drug Discov Ther. 2013; 7(5):178-184.
DOI: 10.5582/ddt.2013.v7.5.178
-
185-188
16,17-dihydroxycyclooctatin, a new diterpene from Streptomyces sp. LZ35.
Zhao GS, Li SR, Wang YY, Hao HL, Shen YM, Lu CH
Drug Discov Ther. 2013; 7(5):185-188.
DOI: 10.5582/ddt.2013.v7.5.185
-
189-195
Makau JN, Watanabe K, Kobayashi N
Drug Discov Ther. 2013; 7(5):189-195.
DOI: 10.5582/ddt.2013.v7.5.189
-
196-200
Effect of Celergen, a marine derivative, on in vitro hepatocarcinogenesis.
Catanzaro R, Zerbinati N, Solimene U, Celep G, Marotta F, Kushugulova A, Milazzo M, Tomella C, Bertuccelli G, Zhumadilov Z
Drug Discov Ther. 2013; 7(5):196-200.
DOI: 10.5582/ddt.2013.v7.5.196
-
201-208
Yamaguchi T, Nakajima N, Nakamura I, Mashiba H, Kawashiro T, Ebara K, Ichimura E, Nishimura C, Okamoto K, Ichikawa Y, Ichida T
Drug Discov Ther. 2013; 7(5):201-208.
DOI: 10.5582/ddt.2013.v7.5.201
-
209-211
Mei L, Xu LZ
Drug Discov Ther. 2013; 7(5):209-211.
DOI: 10.5582/ddt.2013.v7.5.209